Uneven distribution of human papillomavirus 16 in cervical carcinoma in situ and squamous cell carcinoma in older females: A retrospective database study
Authors:
Open Access
- 11 July 2014
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 8 (4) , 1528-1532
Abstract
Human papillomavirus (HPV) 16 is the dominant cofactor in cervical cancer development. The present report investigated the age‑specific prevalence of HPV16 in cervical carcinoma in situ (CIS) in females attending organised cervical cancer screening. A retrospective observational study was performed based on individual data from two databases. A total of 162 females aged between 20 and 65 years from Uppsala County, Sweden with CIS and an HPV test conducted between 2010 and 2011, preceding or concomitant to CIS diagnosis, were included. Females with cervical squamous cell carcinoma (SCC; n=35) were used for comparison. In total, 96% (n=156) of females with CIS were positive for high‑risk HPV; HPV16 was the most prevalent (44.5%), followed by HPV33/52/58 (19.5%), HPV31 (13.1%) and HPV18/45 (9.5%). HPV16 was most frequently detected in females with CIS aged between 20 and 29 years (73.6%) and least frequently detected in those aged between 50 and 65 years (33.3%), with a statistically significant age‑specific difference (P=0.001). Among the HPV16‑positive females, multiple infections were most frequent in the younger age groups. The prevalence of HPV16 in females with CIS decreased with age, whereas a high prevalence of HPV16 remained in females with SCC. These results may indicate that HPV16 has increased oncogenic potential in older females.Keywords
This publication has 22 references indexed in Scilit:
- Self‐sampling of vaginal fluid and high‐risk human papillomavirus testing in women aged 50 years or older not attending Papanicolaou smear screeningBJOG: An International Journal of Obstetrics & Gynaecology, 2011
- Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publicationInternational Journal of Cancer, 2010
- Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide studyThe Lancet Oncology, 2010
- Use of FTA card for dry collection, transportation and storage of cervical cell specimen to detect high-risk HPVJournal of Clinical Virology, 2009
- Comparison between the Hybrid Capture 2 and the hpVIR real-time PCR for detection of human papillomavirus in women with ASCUS or low grade dysplasiaJournal of Clinical Virology, 2009
- A Longitudinal Swedish Study on Screening for Squamous Cell Carcinoma and Adenocarcinoma: Evidence of Effectiveness and OvertreatmentCancer Epidemiology, Biomarkers & Prevention, 2007
- Much Higher Risk of Premalignant and Malignant Cervical Diseases in Younger Women Positive for HPV16 than in Older Women Positive for HPV16Microbiology and Immunology, 2001
- Human papillomavirus is a necessary cause of invasive cervical cancer worldwideThe Journal of Pathology, 1999
- Trends in cancer of the cervix uteri in Sweden following cytological screeningBritish Journal of Cancer, 1999
- Low efficiency of cytologic screening for cancer in situ of the cervix in older womenInternational Journal of Cancer, 1995